Article Versions Notes

Ayala R, Rapado I, Onecha E, Martínez-Cuadrón D, Carreño-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, et al. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers. 2021; 13(10):2458. https://doi.org/10.3390/cancers13102458

Ayala, Rosa, Inmaculada Rapado, Esther Onecha, David Martínez-Cuadrón, Gonzalo Carreño-Tarragona, Juan Miguel Bergua, Susana Vives, Jesus Lorenzo Algarra, Mar Tormo, Pilar Martinez, and et al. 2021. "The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial" Cancers 13, no. 10: 2458. https://doi.org/10.3390/cancers13102458

Ayala, R., Rapado, I., Onecha, E., Martínez-Cuadrón, D., Carreño-Tarragona, G., Bergua, J. M., Vives, S., Algarra, J. L., Tormo, M., Martinez, P., Serrano, J., Herrera, P., Ramos, F., Salamero, O., Lavilla, E., Gil, C., López Lorenzo, J. L., Vidriales, M. B., Labrador, J., ... on behalf of the Programa para el Estudio de la Terapeutica en Hemopatias Malignas (PETHEMA) Cooperative Study Group. (2021). The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers, 13(10), 2458. https://doi.org/10.3390/cancers13102458